Open Access Review

Management of Cardiac Allograft Vasculopathy

Received: 31 May 2017;  Published: 28 September 2017;  doi: 10.21926/obm.transplant.1703005

Abstract

Cardiac allograft vasculopathy(CAV) is one of the leading causes of death following the first 5 years after orthotopic heart transplantation(OHT) along with late graft failure( likely secondary to undiagnosed CAV. Currently there is no single medical treatment available for this condition except m [...]